Efficacy and safety of the Dermatological Soap with ozonized sunflower oil (AGO) and Cream with AGO in patients with Acne.
Not Applicable
- Conditions
- Acne
- Registration Number
- RPCEC00000438
- Lead Sponsor
- ational Center for Scientific Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Patients of both sexes with 19 years old or older, who have acne-type skin lesions, and who agree to participate in the study by signing an informed consent
Exclusion Criteria
Patients with:
• Skin lesions with added infection
• Known hypersensitivity to the products to be used.
• Other skin lesions already diagnosed.
• Severe or grade 3 acne with 21 and 50 inflammatory lesions on one half of the face, or where there are numerous (between 40 and 100) papules or pustules with deep, infiltrating nodular lesions, the areas of lesions extend beyond the face, to the back and back
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure clinical (bsence of acneic skin lesions) or clinical improvement (significant reduction in acne skin lesions). Measurement time: At baseline and, 15, 30, 45 and 60 days of treatment.<br>
- Secondary Outcome Measures
Name Time Method 1. EASI Scale (Eczema Area and Severity Index). Measurement time: At baseline and, 15, 30, 45 and 60 days of treatment.<br>2. Quality of Life (Dermatology Life Quality Index (DLQI)): Measurement time: At baseline and, 15, 30, 45 and 60 days of treatment.